FEBRUARY 2024LIFE SCIENCES REVIEW 19required. This modularity benefits startups that may already have certain financial processes in place but need support only in specific areas.The other side of the coin is the Corporate Finance services that delve into more strategic financial aspects such as company and compound valuations, support in exit strategies including IPOs and sales, and guidance in financing structuring. The company boasts significant connections within the global M&A landscape, chiefly through its association with AICA, a preeminent network in corporate finance. This affiliation stands as the cornerstone of its corporate finance division, providing a substantial framework for cross-border transactions and strategic alliances."While we are not directly engaged in financing, our suite of services is crafted to guide startups from their nascent stages to maturity and potential exit events, offering a comprehensive, end-to-end journey in financial management and strategic planning," says Kaspar Kunz, founding partner.These services are also intricately designed to align with the Swiss legal requirements, addressing the startup's financial compliance needs ­ maintaining accounting records, preparing annual financial statements, and filing tax returns. As these startups evolve, their financial needs become more complex. Particularly in the life sciences sector, where companies typically experience a phase of substantial cash burn without revenue generation, advanced financial planning becomes crucial. This is where Hoffmann & Partner play a more pivotal role.Its expertise lies in translating the intricate details of a startup's development program into a coherent financial framework. This includes creating detailed forecasts and budgets that provide a clear picture of the financial road ahead. More than just number-crunching, this approach offers profound insights into the company's financial health, comparing actuals against projections, pinpointing variances, and deciphering the reasons behind them. This level of analysis is invaluable for startups, as it ensures effective management of investor funds and helps identify the point when additional financing is required.While larger firms offer similar expertise, they may lack the flexibility and cost-effectiveness that startups require. Hoffmann & Partner find their strength in this niche, offering tailored services that resonate well with early-stage startups.Its advisory role took centre stage for a Basel-based company that initiated its operations with an underdeveloped accounting function. Hoffmann & Partner established the company's accounting and controlling systems, laying the groundwork for accurate forecasting and expense tracking. As the company matured, Hoffmann & Partner remained an advisor during the client's exit process, which involved exploring a dual track of selling the company and pursuing an IPO. The team provided the much-needed expertise in creating International Financial Reporting Standards (IFRS) financial statements and drafting the prospectus.The firm's involvement concluded successfully with the company's sale to a major pharmaceutical entity. While this meant the end of services for this particular client, it exemplified Hoffmann & Partner's successful business model--aiding clients in achieving significant milestones in their corporate narrative.As Basel's life sciences and biotech startup ecosystem prioritises efficiency in their financial operations, Hoffmann & Partner wants to remain a partner of choice to optimise their financial operations and contribute to the broader societal advancements in healthcare and biotechnology. While we are not directly engaged in financing, our suite of services is crafted to guide startups from their nascent stages to maturity and potential exit events, offering a comprehensive, end-to-end journey in financial management and strategic planning
< Page 9 | Page 11 >